References

  1. Sarah M Kranick, Avindra Nath. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum Lifelong Leaning Neurol. 2012; 18(6): 1319-1337. PubMed | Google Scholar

  2. Moulonguet A. Neuropathies périphériques au cours de l'infection par le VIH. Rev Neurol (Paris). 2003 Dec ; 159(12) : 1223-6. PubMed | Google Scholar

  3. Sais G & Saimot AG. Manifestations neurologiques et infections rétrovirales. Pradel (Paris). 1991; 123-143. Google Scholar

  4. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D,Vicau E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005 Mar; 114(1-2): 29-36. PubMed | Google Scholar

  5. Attal N, Perrot S, Fermanian J, Bouhassira D. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 questionnaire. J Pain. 2011 Oct; 12(10): 1080-7. PubMed | Google Scholar

  6. Jessica Robinson-Papp, Benjamin B Gelman, Igor Grant, Elyse Singer, Gary Gensier, Susan Morgello. The national NeuroAIDS Tissue Consortium: Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle Neve. 2012 April; 45(4): 471-476. PubMed | Google Scholar

  7. Simpson DM. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol. 2002 Dec; 8 S(uppl 2): 33?41. PubMed | Google Scholar

  8. Verma S, Estaislao L. HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs. 2005; 19(4):325-34. PubMed | Google Scholar

  9. Wadley AL, Cherry CL, Price P, Kamerman PR. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage. 2011 Apr; 41(4):700-6. PubMed | Google Scholar

  10. Henry Namme Luma, Benjamin Clet Nguenkam Tchaleu, Marie Solange Doualla, Elvis Temfack, Victor Nicolas King Sopouassi, Yacouba Njankouo Mapoure, Vincent-Paul Djientcheu. HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study. AIDS Research Therapy. 2012; 9:35. PubMed | Google Scholar

  11. Shurie JS, Deribew A. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals. Ethiop Med J. 2010 Apr; 48(2):85-93. PubMed | Google Scholar

  12. Maiga Y, Toloba Y, M'belesso P, Danièle R, Cissoko Y, Illiassou S, Maiga MY. Neuropathic pain during tuberculosis treatment in Bamako (Mali). Med Sante Trop. 2012 Jul-Sep; 22(3):312-316. PubMed | Google Scholar

  13. Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Peripheral Nerv Syst. 2001 Mar; 6(1):14-20. PubMed | Google Scholar

  14. Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P,Wesselingh SL, Cherry CL. Prevalence and risk factors of HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007 Sep; 8(6):367-373. PubMed | Google Scholar

  15. Henry Namme Luma, Marie-Solange Doualla, Simeon-Pierre Choukem, Elvis Temfack, Gloria Ashuntantang, Henry Achu Joko, Sinata Koulla-Shiro. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon : a cross sectional study. Pan African Medical Journal. 2012; 12:87. PubMed | Google Scholar

&